About Martin Stanton
Form D filings for Mosaic Biosciences from 2011 to 2023 list Martin Stanton as CEO and director.
Martin Stanton first appears on SEC filings in 2011.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Stanton in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Stanton works with at each company, as listed on that company's latest Form D.
Mosaic Biosciences, Inc. · Form D, Jan 6, 2023